AML
Clinical trials for AML explained in plain language.
Never miss a new study
Get alerted when new AML trials appear
Sign up with your email to follow new studies for AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized leukemia vaccine aims to outsmart relapse
⭐️ CURE ⭐️ CompletedThis study tests a personalized vaccine made from a patient's own leukemia cells fused with immune cells, combined with a drug that blocks PD-1, to help the immune system recognize and destroy any remaining leukemia cells after chemotherapy. The goal is to prevent the cancer from…
Matched conditions: AML
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: ⭐️ CURE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Could lenalidomide boost chemo for tough AML?
Disease control CompletedThis phase 2 trial tested whether adding lenalidomide to standard MEC chemotherapy helps adults with relapsed or refractory acute myeloid leukemia (AML) achieve remission. 41 participants received the combination. The main goal was to see how many achieved complete remission. Thi…
Matched conditions: AML
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
First step for new AML drug: safety check in healthy volunteers
Knowledge-focused CompletedThis study tested a new drug called ZE46-0134 in 112 healthy adults to see if it is safe and how the body handles it. The drug is being developed for a type of blood cancer called AML. Since this was the first time the drug was given to people, the main goal was to check for side…
Matched conditions: AML
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC